Overview
Status
Active
Registry date
2020-06-16
Share capital
5,000.00 PLN
Registered address
ul. Prof. Stanisława Łojasiewicza 4, 30-348 Kraków, Poland
Financials
Revenue history
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 269 days for 2022).
- 202519/06/2026
- 202403/07/2025
- 202329/04/2024
- 202209/04/2024
- 202102/08/2022
- 202029/06/2021
Filed on timeDelayFiling deadline
The statements for 2020 report only zeros (no activity).
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Ewa Łucja Stępień – President of the Management Board
Paweł Moskal – Management Board Member
Manner of representation
Two members of the management board acting in agreement, or a commercial proxy acting jointly with a member of the management board; in the case of a one-person management board, the President of the Management Board personally.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 10 | $135.06 | 10% | |
Agnieszka Kamińskaage 38 | 30 | $405.19 | 30% |
Ewa Łucja Stępieńage 58 | 60 | $810.37 | 60% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org | ||
| SelvitaS.A. | – | selvita.com |
FAQ
The main business activity of Theranoscope focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on June 16, 2020.
The headquarters is located at: ul. Prof. Stanisława Łojasiewicza 4, 30-348 Kraków.
The management board includes Paweł Moskal (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-06-19